Latest Insider Transactions at Teva Pharmaceutical Industries LTD (TEVA)
This section provides a real-time view of insider transactions for Teva Pharmaceutical Industries LTD (TEVA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TEVA PHARMACEUTICAL INDUSTRIES LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TEVA PHARMACEUTICAL INDUSTRIES LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,774
+43.59%
|
-
|
|
Feb 09
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,538
+44.7%
|
-
|
|
Nov 03
2020
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
212,314
+30.54%
|
-
|
|
Nov 01
2020
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
180,000
+39.96%
|
-
|